Target intelligence / Profile preview

Immunoglobulin heavy variable (II)-28-1 (pseudogene) (IGHVII-28-1)

Target
IGHVII-28-1
Molecular classification
Other, Immunoglobulin gene segment, Pseudogene
01

Overview

Immunoglobulin heavy variable (II)-28-1 (IGHVII-28-1) is classified as a pseudogene found in the human immunoglobulin heavy chain locus on chromosome 14[2][4][6][8]. As a pseudogene, it does not encode a functional immunoglobulin heavy chain variable region and therefore does not contribute to antigen recognition or to the formation of antibody molecules. Immunoglobulin heavy variable regions are typically important for the diversity and antigen specificity of antibody molecules produced by B lymphocytes[1][5]. However, IGHVII-28-1 lacks protein-coding capability and is not considered a therapeutic target, nor does it have known roles in human disease, drug interaction, or function as a biomarker[2][4][6][8]. Its main relevance lies in immunogenomics and antibody gene locus organization studies, not in clinical targeting. \n\nKey point: IGHVII-28-1 is a human immunoglobulin heavy variable region pseudogene, not a functional protein or therapeutic target[2][4][6][8].

Other names
IGHV(II)-28-14-28.1PIGHVII281IGHVII-28-1immunoglobulin heavy variable (II)-28-1 pseudogene

Beyond the preview

Go deeper on Immunoglobulin heavy variable (II)-28-1 (pseudogene) (IGHVII-28-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable (II)-28-1 (pseudogene) (IGHVII-28-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call